Bain Capital Public Equity Management Ii, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Bain Capital Public Equity Management Ii, LLC

$1.99 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $25.3 Million - $45.3 Million	-3,039,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $27.8 Million - $40.4 Million	3,039,000 New	3,039,000 $35.2 Million

Others Institutions Holding DNA

# of Institutions

Shares Held

48.4M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$302 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$16.6 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$10.8 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$8.23 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$1.69 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account